Excited to share my co-author @YdeEric's job market paper! He studies vertical integration between insurers and pharmacies and finds that integration raises drug prices and harms consumers.
Eric is on the job market this year and he is an exceptional scholar to watch!
This Post is from an account that no longer exists. Learn more
Lawsuit ads warn viewers about alleged risks of specific prescription drugs and encourage them to join potential lawsuits. In my paper, now available online at Management Science, I study how such drug injury ads affect drug use and health outcomes.
Drug injury ads fall under the FTC and face less scrutiny than DTCA, yet there are rising concerns from physicians about the accuracy of the ads. Given the potential negative public health impacts, my findings support continued oversight of drug injury advertising.
Governments often regulate prices (e.g., capping drug prices or taxing unhealthy goods) to achieve policy goals. But what happens when firms respond strategically? In our new Management Science paper, we study how pharma firms adjust promotions under the 340b Program.
The implications extend beyond pharmaceuticals. Think soda or alcohol taxes. If firms can re-optimize promotional effort across their product lines, targeted policies may miss their mark.
The FTC's case against PepsiCo highlights how promotional payments can give big-box retailers an unfair advantage. My research shows that side payments are just as important as wholesale price discounts in supplier negotiations. #FTC #econtwitter
In my Marketing Science paper, I further show that smaller retailers are more likely to distort assortments to gain leverage in contract negotiations. Without scale, assortment control becomes a key tool for securing preferential contracts from suppliers.
Thrilled to be working with @JuraWho and Leo on such an important topic! The paper documents how purchasing patterns change with adoption of GLP-1 medications, exploring changes across key dimensions like motivation, age, and income.
🚨Closing out 2024 with new paper with @hristakevas and Leo Feler: How GLP-1 medications like Ozempic are reshaping food demand and changing the rules of the game for the food industry.
Sylvia Hristakeva retweeted
Are you a rising dictator struggling to spread online propaganda? Look no further — our paper (w/ @justinmrao) just out at @JPolEcon can teach you what gets people to consume your puppet news outlets
journals.uchicago.edu/doi/10…
A (joking) thread (on our serious paper). 1/N
Julie Mortimer and I are hiring an RA for next year to work on an NSF funded project studying the market for television advertising in the United States. The position is open to currently enrolled PhD students.
Information here: hristakeva.com/wp-content/up…
@econ_ra #econtwitter
Sylvia Hristakeva retweeted
And that’s a wrap! I am thrilled to announce I will be joining UCLA Anderson as an Assistant Professor of Marketing Fall 2021!
Sylvia Hristakeva retweeted
Share with your PhD students: NBER Digitization (virtual) PhD workshop, March 17-18. Applications due November 16. nber.org/call-applications-e…